Determination of 
breast and gastric cancers, tumor
TUMOR
Although the cutoffs for HER2‐positivity in breast and gastric cancers may be useful in defining similar values in other tumor types, the thresholds for treatment benefit may differ across indications. Thus, in preparation for KAMELEON (